Abstract
Spectinomycin, a tricyclic aminoglycoside antibiotic with peculiar chemical structure and pharmacological profile was characterized in terms of microscopic protonation constants. 1H-15N HMBC–pH titrations were carried out to allocate the order of basicities of the two similar methylamino functions of spectinomycin, and 1H NMR–pH titrations were performed on spectinomycin and actinamine, its symmetrical model compound to determine the basicity of the amino sites. It was found that the methylamino moiety in position 3 is of some 60% higher basicity than its counterpart in position 1, and protonation at one site decreases the basicity of the other site by 1.17 logk units. Both secondary amino sites as such are of relatively low basicity, due to the adjacent, electron-withdrawing 7 oxygens. At the pH of blood nearly equal amounts of di- and monocationic species coexist, while less than 1% of neutral spectinomycin occurs at this pH. The pHdependent distribution of the microspecies is depicted.
Keywords: Spectinomycin, microspeciation, 1H and 15N NMR-pH titration, site-specific basicities, pH-dependent species distribution.
Current Pharmaceutical Analysis
Title:The Site-specific Protonation Constants of Spectinomycin, Characterized by 1H and 15N NMR Methods
Volume: 11 Issue: 1
Author(s): Mate Somlyay, Gabor Orgovan and Bela Noszal
Affiliation:
Keywords: Spectinomycin, microspeciation, 1H and 15N NMR-pH titration, site-specific basicities, pH-dependent species distribution.
Abstract: Spectinomycin, a tricyclic aminoglycoside antibiotic with peculiar chemical structure and pharmacological profile was characterized in terms of microscopic protonation constants. 1H-15N HMBC–pH titrations were carried out to allocate the order of basicities of the two similar methylamino functions of spectinomycin, and 1H NMR–pH titrations were performed on spectinomycin and actinamine, its symmetrical model compound to determine the basicity of the amino sites. It was found that the methylamino moiety in position 3 is of some 60% higher basicity than its counterpart in position 1, and protonation at one site decreases the basicity of the other site by 1.17 logk units. Both secondary amino sites as such are of relatively low basicity, due to the adjacent, electron-withdrawing 7 oxygens. At the pH of blood nearly equal amounts of di- and monocationic species coexist, while less than 1% of neutral spectinomycin occurs at this pH. The pHdependent distribution of the microspecies is depicted.
Export Options
About this article
Cite this article as:
Somlyay Mate, Orgovan Gabor and Noszal Bela, The Site-specific Protonation Constants of Spectinomycin, Characterized by 1H and 15N NMR Methods, Current Pharmaceutical Analysis 2015; 11 (1) . https://dx.doi.org/10.2174/1573412910666140917213713
DOI https://dx.doi.org/10.2174/1573412910666140917213713 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Applications of Diphenylamine and Its Derivative as Potent Bioactive Compound: A Review
Current Bioactive Compounds Metal-Based Antimicrobial Protease Inhibitors
Current Medicinal Chemistry Graphical Abstracts:
Letters in Drug Design & Discovery Meet the Editorial Board:
Current Medicinal Chemistry Epoxide Hydrolases and their Application in Organic Synthesis
Current Organic Chemistry The Spectrum of Cefditoren for Lower Respiratory Tract Infections (LRTIs) in Surabaya
Current Drug Therapy Editorial [Hot topic: QSAR and Complex Networks in Pharmaceutical Design, Microbiology, Parasitology, Toxicology, Cancer and Neurosciences (Executive Editor: Humberto Gonzalez-Diaz)]
Current Pharmaceutical Design Anti-TNF Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Scanning the Genome of Mycobacterium tuberculosis to Identify Potential Lectins
Protein & Peptide Letters Antibiotic Sensitivity of Bacillus clausii Strains in Commercial Preparation
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Autophagy and Crohns Disease: At the Crossroads of Infection, Inflammation, Immunity, and Cancer
Current Molecular Medicine Microbial Efflux Pump Inhibition: Tactics and Strategies
Current Pharmaceutical Design P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets The Unbiased Search of Biomarkers in Neurodegenerative Diseases
Current Pharmaceutical Biotechnology Structural Characterization of Alpha-methylacyl-CoA Racemase: Comparative Structural Modeling, Molecular Docking and Dynamic Simulations Studies
Current Cancer Drug Targets Pyrazinamide and Pyrazinoic Acid Derivatives Directed to Mycobacterial Enzymes Against Tuberculosis
Current Protein & Peptide Science In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18
Current Topics in Medicinal Chemistry Chemistry and Applications of 4-Hydroxyquinolin-2-one and Quinoline-2,4-dionebased Compounds
Current Organic Chemistry Thiazolides, a Novel Class of Anti-Infective Drugs, Effective Against Viruses, Bacteria, Intracellular and Extracellular Protozoan Parasites and Proliferating Mammalian Cells
Anti-Infective Agents The Role of T-Helper Cells in Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry